Phospholipid compositions and their preparation
US-2016339062-A1 · Nov 24, 2016 · US
US10543237B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10543237-B2 |
| Application number | US-201816023146-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 29, 2018 |
| Priority date | Mar 28, 2007 |
| Publication date | Jan 28, 2020 |
| Grant date | Jan 28, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO 2 or CO 2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO 2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.
Opening claim text (preview).
The invention claimed is: 1. A method of increasing muscle mass in a subject comprising administering to the subject an effective amount of a krill oil composition under conditions such that muscle mass is increased, the krill oil composition comprising from 3% to 10% ether phospholipids w/w of said krill oil; from about 27% to 50% non-ether phospholipids w/w of said krill oil so that the amount of total phospholipids in the composition is from about 30% to 60% w/w of said krill oil; from about 20% to 50% triglycerides w/w of said krill oil, and astaxanthin esters in amount of greater than about 100 mg/kg of said krill oil. 2. The method of claim 1 , wherein the subject is a human subject. 3. The method of claim 1 , wherein protein catabolism is decreased in the subject. 4. The method of claim 1 , wherein the effective amount of krill oil is a daily dose of from 0.2 to 10 grams/day. 5. The method of claim 1 , wherein the effective amount of krill oil is provided in a soft gel capsule. 6. A method of increasing muscle mass in a human subject comprising administering to the human subject from 0.2 to 10 grams/day of a krill oil composition under conditions such that muscle mass is increased, the krill oil composition comprising from 3% to 10% ether phospholipids w/w of said krill oil; from about 27% to 50% non-ether phospholipids w/w of said krill oil so that the amount of total phospholipids in the composition is from about 30% to 60% w/w of said krill oil; from about 20% to 50% triglycerides w/w of said krill oil, and astaxanthin esters in amount of greater than about 100 mg/kg of said krill oil.
Nutrients, e.g. vitamins, minerals · CPC title
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title
Organic compounds · CPC title
having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin · CPC title
Fatty acids or derivatives thereof; Fats or oils · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.